This announcement is a separate document:
大参林医药集团股份有限公司2022年前三季度业绩预告
Dashanlin Pharmaceutical Group Co., Ltd. performance forecast for the first three quarters of 2022
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.